Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
US7385085B2 · kind B2 · utility
2Cited by
23References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2005 |
| Grant date | Jun 10, 2008 |
| Priority date | — |
| Expiry date | Jul 15, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.